vs
PUMA BIOTECHNOLOGY, INC.（PBYI）とStock Yards Bancorp, Inc.（SYBT）の財務データ比較。上の社名をクリックして会社を切り替えられます
Stock Yards Bancorp, Inc.の直近四半期売上が大きい（$104.4M vs $75.5M、PUMA BIOTECHNOLOGY, INC.の約1.4倍）。PUMA BIOTECHNOLOGY, INC.の前年同期比売上増加率が高い（27.7% vs 11.7%）。Stock Yards Bancorp, Inc.の直近四半期フリーキャッシュフローが多い（$154.0M vs $14.4M）。過去8四半期でPUMA BIOTECHNOLOGY, INC.の売上複合成長率が高い（31.3% vs 11.9%）
プーマ・バイオテクノロジーは上場済みの生物医薬品企業で、本社はアメリカ合衆国カリフォルニア州ロサンゼルスに位置し、革新的な医薬品の研究開発を中心に事業を展開しています。
Stock Yards Bancorp, Inc.はアメリカの地方銀行持株会社で、1903年にパイクビル国立銀行として設立されました。現在も本社はアパラチアの中心部にあるケンタッキー州パイクビルに置かれ、商業銀行のCommunity Trust Bankと、レキシントンにある信託会社Community Trust and Investment Companyを運営しています。
PBYI vs SYBT — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $75.5M | $104.4M |
| 純利益 | — | $36.6M |
| 粗利率 | 69.3% | — |
| 営業利益率 | 22.7% | 45.9% |
| 純利益率 | — | 35.1% |
| 売上前年比 | 27.7% | 11.7% |
| 純利益前年比 | — | 15.5% |
| EPS（希薄化後） | $0.26 | $1.24 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $75.5M | $104.4M | ||
| Q3 25 | $54.5M | $101.5M | ||
| Q2 25 | $52.4M | $97.8M | ||
| Q1 25 | $46.0M | $93.5M | ||
| Q4 24 | $59.1M | $93.5M | ||
| Q3 24 | $80.5M | $89.8M | ||
| Q2 24 | $47.1M | $85.7M | ||
| Q1 24 | $43.8M | $83.3M |
| Q4 25 | — | $36.6M | ||
| Q3 25 | $8.8M | $36.2M | ||
| Q2 25 | $5.9M | $34.0M | ||
| Q1 25 | $3.0M | $33.3M | ||
| Q4 24 | — | $31.7M | ||
| Q3 24 | $20.3M | $29.4M | ||
| Q2 24 | $-4.5M | $27.6M | ||
| Q1 24 | $-4.8M | $25.9M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | 45.9% | ||
| Q3 25 | 17.6% | 45.0% | ||
| Q2 25 | 12.7% | 43.9% | ||
| Q1 25 | 8.7% | 44.5% | ||
| Q4 24 | 22.6% | 41.9% | ||
| Q3 24 | 27.4% | 41.2% | ||
| Q2 24 | -4.6% | 41.2% | ||
| Q1 24 | -5.3% | 39.5% |
| Q4 25 | — | 35.1% | ||
| Q3 25 | 16.2% | 35.7% | ||
| Q2 25 | 11.2% | 34.8% | ||
| Q1 25 | 6.5% | 35.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | 25.2% | 32.7% | ||
| Q2 24 | -9.6% | 32.2% | ||
| Q1 24 | -11.0% | 31.1% |
| Q4 25 | $0.26 | $1.24 | ||
| Q3 25 | $0.17 | $1.23 | ||
| Q2 25 | $0.12 | $1.15 | ||
| Q1 25 | $0.06 | $1.13 | ||
| Q4 24 | $0.40 | $1.07 | ||
| Q3 24 | $0.41 | $1.00 | ||
| Q2 24 | $-0.09 | $0.94 | ||
| Q1 24 | $-0.10 | $0.88 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $97.5M | — |
| 総負債低いほど良い | $22.7M | $26.8M |
| 株主資本純資産 | $130.3M | $1.1B |
| 総資産 | $216.3M | $9.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.17× | 0.02× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
| Q4 25 | $22.7M | $26.8M | ||
| Q3 25 | $34.0M | $26.8M | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $26.8M | ||
| Q4 24 | $68.0M | $26.8M | ||
| Q3 24 | $79.3M | $26.8M | ||
| Q2 24 | $90.7M | $26.8M | ||
| Q1 24 | $102.0M | $26.8M |
| Q4 25 | $130.3M | $1.1B | ||
| Q3 25 | $115.3M | $1.0B | ||
| Q2 25 | $104.7M | $1.0B | ||
| Q1 25 | $97.1M | $975.5M | ||
| Q4 24 | $92.1M | $940.5M | ||
| Q3 24 | $71.1M | $934.1M | ||
| Q2 24 | $48.5M | $894.5M | ||
| Q1 24 | $51.0M | $874.7M |
| Q4 25 | $216.3M | $9.5B | ||
| Q3 25 | $202.9M | $9.3B | ||
| Q2 25 | $194.9M | $9.2B | ||
| Q1 25 | $196.2M | $9.0B | ||
| Q4 24 | $213.3M | $8.9B | ||
| Q3 24 | $220.7M | $8.4B | ||
| Q2 24 | $205.0M | $8.3B | ||
| Q1 24 | $214.1M | $8.1B |
| Q4 25 | 0.17× | 0.02× | ||
| Q3 25 | 0.30× | 0.03× | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | 0.03× | ||
| Q4 24 | 0.74× | 0.03× | ||
| Q3 24 | 1.12× | 0.03× | ||
| Q2 24 | 1.87× | 0.03× | ||
| Q1 24 | 2.00× | 0.03× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $14.4M | $166.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $14.4M | $154.0M |
| FCFマージンFCF / 売上 | 19.1% | 147.5% |
| 設備投資強度設備投資 / 売上 | 0.0% | 11.5% |
| キャッシュ転換率営業CF / 純利益 | — | 4.54× |
| 直近12ヶ月FCF直近4四半期 | $41.7M | $260.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $14.4M | $166.0M | ||
| Q3 25 | $9.7M | $38.2M | ||
| Q2 25 | $14.1M | $55.9M | ||
| Q1 25 | $3.6M | $19.8M | ||
| Q4 24 | $15.6M | $142.9M | ||
| Q3 24 | $11.0M | $55.4M | ||
| Q2 24 | $1.0M | $51.1M | ||
| Q1 24 | $11.2M | $17.4M |
| Q4 25 | $14.4M | $154.0M | ||
| Q3 25 | $9.7M | $35.2M | ||
| Q2 25 | $14.1M | $53.5M | ||
| Q1 25 | $3.6M | $17.8M | ||
| Q4 24 | $15.6M | $133.0M | ||
| Q3 24 | $11.0M | $53.9M | ||
| Q2 24 | $1.0M | $47.9M | ||
| Q1 24 | — | $15.6M |
| Q4 25 | 19.1% | 147.5% | ||
| Q3 25 | 17.7% | 34.6% | ||
| Q2 25 | 26.8% | 54.7% | ||
| Q1 25 | 7.7% | 19.1% | ||
| Q4 24 | 26.4% | 142.3% | ||
| Q3 24 | 13.7% | 60.0% | ||
| Q2 24 | 2.1% | 55.9% | ||
| Q1 24 | — | 18.7% |
| Q4 25 | 0.0% | 11.5% | ||
| Q3 25 | 0.0% | 3.0% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.0% | 10.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 3.8% | ||
| Q1 24 | 0.0% | 2.2% |
| Q4 25 | — | 4.54× | ||
| Q3 25 | 1.10× | 1.05× | ||
| Q2 25 | 2.41× | 1.64× | ||
| Q1 25 | 1.21× | 0.59× | ||
| Q4 24 | — | 4.51× | ||
| Q3 24 | 0.54× | 1.89× | ||
| Q2 24 | — | 1.85× | ||
| Q1 24 | — | 0.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
